LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · IEX Real-Time Price · USD
2.640
+0.010 (0.38%)
At close: May 24, 2024, 3:59 PM
2.610
-0.030 (-1.14%)
After-hours: May 24, 2024, 4:00 PM EDT

LAVA Therapeutics Revenue

LAVA Therapeutics had revenue of $13.63M in the twelve months ending March 31, 2024, down -36.01% year-over-year. Revenue in the quarter ending March 31, 2024 was $7.60M with 471.24% year-over-year growth. In the year 2023, LAVA Therapeutics had annual revenue of $7.52M, a decrease of -63.54%.

Revenue (ttm)
$13.63M
Revenue Growth
-36.01%
P/S Ratio
5.09
Revenue / Employee
$368,302
Employees
37
Market Cap
69.40M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.52M-13.11M-63.54%
Dec 31, 202220.63M14.55M239.31%
Dec 31, 20216.08M1.51M33.05%
Dec 31, 20204.57M--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.